FindHealthNews Index  |  Save/Exchange Information |  WikiWax

    News, Reviews, and Articles on Bacterial Vaginosis



    KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results  Aug 12, 2008
    Clindesse(R), indicated for the treatment of bacterial vaginosis (BV) in non-pregnant women, continues to experience growing prescription trends in the anti-infective category. Currently, Clindesse(R) carries a 27. (PR Newswire)

    Bacterial Vaginosis and HIV Infecti...  Aug 3, 2008
    Bacterial Vaginosis and HIV Infection: Increased Risk for AIDS and Sexually Transmitted Diseases ... Bacterial Vaginosis and HIV Infection ... Bacterial Vaginosis and HIV Infection. (Suite101.com)

    UNC study: Common vaginal infection may increase risk of HIV infection  Aug 1, 2008
    An analysis of 23 published studies, including data from more than 30,700 women from around the world, showed that women with bacterial vaginosis the most common type of vaginosis in women of reproductive age were more likely than others to be infected with HIV. The association between bacterial vaginosis (BV) and HIV was stronger for women without high-risk sexual behavior ... "Given that bacterial vaginosis and HIV infection are both transmitted sexually, it is difficult to determine... (EurekAlert!)

    KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis  Feb 28, 2008
    9% of total prescription volume in the intra-vaginal bacterial vaginosis market, more than all other Clindomycin-based intra-vaginal products combined -- Gynazole-1(R) remains the #1 branded prescription vaginal yeast product in the United States -- Ther-Rx continues to be the leading provider of prescription prenatal vitamins in the United States with 42. 5% of the branded prescription prenatal market -- Repliva 21/7(TM) continues to be the fastest growing prescription oral iron supplement in... (PR Newswire)

    Screening Pregnant Women for Bacterial Vaginosis Not Recommended  Feb 6, 2008
    NEW YORK (Reuters Health) - The US Preventive Services Task Force is advising doctors not to screen pregnant women for bacterial vaginosis, commonly referred to as BV, if they are at low risk for preterm delivery -- because treating BV offers no benefit ... "Given the lack of net benefit, the USPSTF recommends against routine screening for bacterial vaginosis in low-risk, pregnant women," the report concludes. (MEDLINEplus)

    Summary for Patients  Feb 5, 2008
    Screening for Bacterial Vaginosis in Pregnancy to Prevent Preterm Delivery: U.S. Preventive Services Task Force Recommendation Statement -- U.S. Preventive Services Task Force 148 (3): 214 -- Annals of Internal Medicine ... Screening Pregnant Women for Bacterial Vaginosis: U.S. Preventive Services Task Force Recommendations ... The summary below is from the full reports titled "Screening for Bacterial Vaginosis in Pregnancy to Prevent Preterm Delivery: U.S. Preventive Services Task Force... (Annals of Internal Medicine)

    Surprising research results at AIDS conference  Feb 5, 2008
    These women had a 25 percent lower rate of infection with genital herpes; a 50 percent reduction in trichomoniasis - a common sexually transmitted disease caused by a parasite - and a 20 percent reduction in bacterial vaginosis. These kinds of infections tend to increase the risk of HIV infection in women, but this study was not designed to find out whether that indeed had happened. (San Francisco Chronicle)

    Bacterial Vaginosis Doubles Risk of Miscarriage  Dec 29, 2007
    NEW YORK (Reuters Health) - The presence of bacterial vaginosis or BV during the first trimester of pregnancy doubles the likelihood of a miscarriage by the end of the second trimester, researchers report. BV -- vaginal inflammation caused by the bacterium Gardnerella vaginalis -- is known to increase the chances of preterm delivery. (MEDLINEplus)

    Condom Use Reduces Risk of Bacterial Vaginosis  Nov 14, 2007
    NEW YORK (Reuters Health) - For women who have a high risk of contracting a sexually transmitted disease, their risk of developing bacterial vaginosis and the associated changes in vaginal microflora is reduced if they use condoms during every sexual encounter, according to a report in the journal Epidemiology. Bacterial vaginosis is caused by an imbalance of the bacteria normally found in a woman's vagina, referred to as vaginal microflora, which is upset by an overgrowth of bacteria not... (MEDLINEplus)

    APHA Adopts New Policies on Food Safety, Global Climate Change, Multidrug-Resistant Organisms, Breastfeeding and Feminine Hygiene  Nov 7, 2007
    Research has shown a relationship between vaginal douching and several adverse health outcomes, including pelvic inflammatory disease, bacterial vaginosis, cervical cancer, HIV transmission and infertility. APHA therefore urges the U.S. Food and Drug Administration to review its regulations on feminine hygiene douching products and require research on the safety of douching. (PR Newswire)

    Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women  Nov 7, 2007
    Bacterial vaginosis (BV), the etiology of which is still uncertain, increases the risk of preterm birth. Recent PCR-based studies suggested that BV is associated with complex vaginal bacterial communities, including many newly recognized bacterial species in non-pregnant women. (BioMed Central)

    Final Report of Ushercell as Treatment for Bacterial Vaginosis Released  Sep 17, 2007
    TORONTO, Sept. 17, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (NasdaqCM: - ) announces that a final report has been received from Dr. Jose Simoes, the Principal Investigator in a Phase II human clinical trial of Ushercell to study the potential treatment and possible prevention of bacterial vaginosis (BV). Bacterial Vaginosis is the most common vaginal disorder among reproductive-age women, commonly associated with several gynecologic and obstetric complications ... In this trial,... (Primezone Releases)

    Here's one urine test you'll want to take  Aug 28, 2007
    Could be bacterial vaginosis or a yeast infection, a bad urinary tract infection, kidney stones or other urinary tract diseases. See a physician promptly, and alert the physician about any changes in the way you urinate (flow, pain or urgency). (Fresno Bee)

    Race a factor for common vaginal infection  Aug 17, 2007
    NEW YORK (Reuters Health) - A pregnant woman's risk of bacterial vaginosis, the most common type of vaginal infection and a risk factor for preterm birth, is doubled if she or her male partner is black ... Bacterial vaginosis, which is not sexually transmitted, occurs when there is an overgrowth of certain bacteria in the vagina ... "An important risk factor for preterm birth is bacterial vaginosis, for which there is also a racial disparity," he added. (Scientific American)

    Risk of common vaginal infection linked to preterm birth appears higher for blacks  Aug 12, 2007
    When a pregnant woman has bacterial vaginosis, her risk of preterm birth goes up, said Hyagriv Simhan, M.D., M.S.C.R., assistant professor of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh School of Medicine. And now we can say that gauging risk for bacterial vaginosis is not as simple as just looking at the woman ... Bacterial vaginosis (BV) is a common gynecological infection that affects up to 50 percent of women in some populations. (EurekAlert!)

    IUDs safe and effective in high-risk patients  Aug 6, 2007
    Additionally, 32 percent of women had a history of other gynecological infections such as bacterial vaginosis, and almost half were unmarried. Matthews said that the Mirena IUS had lower rates of complications and greater acceptability than the Paragard IUD.. (EurekAlert!)

    Analysis of Ushercell HIV Trials Reveals Difference in Seroconversion Groups Not Statistically Significant  Jul 25, 2007
    We are also awaiting results from a small Phase II trial in Brazil to determine if Ushercell may be effective in preventing bacterial vaginosis, which may lead to further development of this compound for additional uses. . (Primezone Releases)

    University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.  Jul 19, 2007
    Marketed under the leading brand name of QuickVue, the portfolio currently includes tests that aid in the diagnosis of several disease or condition states, including influenza, respiratory syncytial virus, Fecal Occult Blood, Strep A, pregnancy, bacterial vaginosis, infectious mononucleosis, H. pylori and Chlamydia. Quidel's products are sold to healthcare professionals with a focus on the physician office lab and acute care markets through leading medical distribution partners on a worldwide... (EurekAlert! -- Business News)

    Frequent Yeast Infections May Be Linked To Certain Vaginal Bacteria Ecosystems  Jul 13, 2007
    Women suffer from insidious health problems, including bacterial vaginosis and yeast infections, and those problems send them in droves to seek medical treatment, said Larry Forney, a professor of biology at the University of Idaho ... When the pH is imbalanced, a condition known as bacterial vaginosis can develop; the condition is not well understood and is marked by several indicators including elevated pH levels and vaginal discharge. (Science Daily)

    Treating Silent Bacterial Vaginosis May Curb STDs  Jul 11, 2007
    In the study, treatment of symptomless bacterial vaginosis with metronidazole resulted in lower rates of chlamydia infection, a common STD, than no treatment, Dr. Jane R. Schwebke told Reuters Health. Bacterial vaginosis -- the most common type of vaginal infection in women of childbearing age -- occurs when there is imbalance in the bacteria of the vagina favoring certain "bad" microbes over "good" ones ... Some women with bacterial vaginosis report no signs or symptoms at all. (MEDLINEplus)

    New Treatment for Common Genital Infection  May 26, 2007
    THURSDAY, May 24 (HealthDay News) -- The U.S. Food and Drug Administration has approved Tindamax (tinidazole) to treat bacterial vaginosis (BV), the most common vaginal infection among women of childbearing age, drug maker Mission Pharmacal said Thursday. It's the first new oral therapy in a decade to treat BV, which affects almost one-third of women in the United States, the company said. (MEDLINEplus)

    FDA OK's local drug company's treatment for bacterial vaginosis  May 25, 2007
    The U.S. Food and Drug Administration approved 's oral medication Tindamax for the treatment of bacterial vaginosis -- the first new oral treatment for the disease in a decade. Bacterial vaginosis is the most common vaginal infection among women of childbearing age in the United States. (San Antonio Business Journal, TX)

    Bacterial vaginosis  Apr 14, 2007
    Shift in vaginal flora. The pH is the vagina is normally acidic (pH <4. (Suite101.com)

    Something fishy  Mar 26, 2007
    BV, or bacterial vaginosis, is the most common cause of abnormal vaginal discharge in the United States ... If you remember your high school Latin you'll note that "bacterial vaginosis" is actually a misnomer, since it literally means "bacteria with an excess of vaginas." "Vaginal Bacteriosis" would make a lot more sense, but then again a vaginal discharge by any name still doesn't smell very sweet. (The Cavalier Daily, VA)

    Frost & Sullivan "Enabling Technology of the Year Award 2006" Goes to Succesful Swiss Pharma - Startup: AmVac AG  Feb 22, 2007
    Femivac(R), the immune-therapeutic vaccine for the treatment of Bacterial Vaginosis and Trichomoniasis has shown convincing efficacy and safety profiles with sustained protectiveness and higher effectiveness compared to commonly used drugs. Prostavac(R) is the world's first patented immune-therapeutic vaccine for the treatment of Benign Prostatic Hyperplasia (BPH) and acute/chronic Prostatitis. (PR Newswire)

    Longer treatment may put end to recurring infection  Feb 19, 2007
    DEAR DR. DONOHUE: I have had recurrent bacterial vaginosis for more than two years ... Bacterial vaginosis is the most common vaginal infection ... Metronidazole is an antibiotic that can usually put an end to bacterial vaginosis. (The Standard-Times, MA)

    Understanding a pap smear result  Feb 19, 2007
    Infection a pap smear can often detect infections such as candida, bacterial vaginosis or trichomonas. Candida and bacterial vaginosis are not usually treated unless you have symptoms. (iAfrica.com)

    Virginal Woman May Pick Up "Bad" Vaginal Bacteria  Nov 14, 2006
    Both types of bacteria can cause bacterial vaginosis (BV), in which the normal oxygen-requiring healthy bacteria of the vagina are replaced by non-oxygen-requiring, or anaerobic, bugs, Tabrizi's team notes in the medical journal Sexually Transmitted Diseases. BV has been linked to miscarriage and a greater susceptibility to sexually transmitted infections such as HIV, but 50 percent of the time, women with BV have no symptoms. (MEDLINEplus)

    FDA CAPSULES  Nov 7, 2006
    FDA APPROVES FIRST GENERIC METRONIDAZOLE. The Food and Drug Administration has approved the first generic version of MetroGel-Vaginal (metronidazole vaginal gel), a treatment for bacterial vaginosis ... Bacterial vaginosis is a condition in women that is characterized by vaginal discharge and results from an overgrowth of bacteria in the vagina. (Newsday -- Health)

    Generic Metronidazole Approved  Nov 3, 2006
    WEDNESDAY, Nov. 1 (HealthDay News) -- The first generic version of MetroGel-Vaginal (metronidazole vaginal gel) has been approved by the U.S. Food and Drug Administration to treat bacterial vaginosis, the agency said Wednesday. The condition, caused by an overgrowth of vaginal bacteria, may be accompanied by symptoms including discharge, odor, pain, itching or burning, the U.S. Centers for Disease Control and Prevention (CDC) says. (MEDLINEplus)

    Acute Vulvovaginitis  Sep 21, 2006
    Please for full text and personal services. Volume 355:1244-1252. (New England Journal of Medicine)

    Mission files drug application with FDA to treat women with bacterial vaginosis  Aug 18, 2006
    has submitted a supplemental new drug application with the U.S. Food and Drug Administration for Tindamax as an approved treatment for bacterial vaginosis ... 5 million prescriptions are written for bacterial vaginosis each year ... Company officials say if the supplemental new drug application is approved by the FDA, Tindamax should provide a shorter oral treatment option than the current standard of care used to treat bacterial vaginosis. (San Antonio Business Journal, TX)

    Vaginal Infections More Prevalent Among Black Women  May 12, 2006
    NEW YORK (Reuters Health) - In the United States, bacterial vaginosis disproportionately affects African American women, according to research reported Wednesday in Jacksonville, Florida at the 2006 National STD Prevention Conference sponsored by the Centers for Disease Control and Prevention ... 3 percent) have bacterial vaginosis ... "Black women were about twice as likely as either white women, who had a prevalence of 22 percent, or Mexican-American women, who had a prevalence of 28 percent,... (MEDLINEplus)

    Review Shows Male Circumcision Protects Female Partners From HIV And Other STDs  Feb 15, 2006
    Male circumcision also reduced rates of trichomonas and bacterial vaginosis in female partners. The study is believed to be the first to demonstrate the benefits to female partners of male circumcision. (Science Daily)

    Male Circumcision Protects Women From AIDS - Study  Feb 10, 2006
    Circumcision also reduced the risk of infection with other sexually transmitted diseases such as trichomonas and bacterial vaginosis, but not syphilis, gonorrhea or chlamydia, the researchers told an AIDS meeting in Denver. Dr. Thomas Quinn of Johns Hopkins University in Baltimore has been leading a team that is studying transmission of the human immunodeficiency virus that causes AIDS in 12,000 volunteers in Rakai, Uganda. (MEDLINEplus)

    KV Pharmaceutical Reports Record Revenues for Fiscal 2006 Third...  Feb 7, 2006
    " For the nine months ended December 31, 2005, consolidated net revenues increased 21% to $280.2 million, compared with $232.3 million for the corresponding year-ago period, as the Ther-Rx branded products division experienced a 68% growth in revenues in addition to the 4% growth in revenues reported by the ETHEX generic/non-branded division, compared with the prior year period. As a result of the write-off of $30.4 million in-process research and development costs ($0.61 per diluted share for... (CNBC -- Research Alerts)

    Pregnancy drug 'doubles premature birth risk'  Jan 16, 2006
    The drug is generally prescribed for the condition bacterial vaginosis (BV), which is an infection linked with premature deliveries. Tommy's said that about 5% of the antenatal population were screened for BV, with one in 10 tests coming out positive. (Daily Mail - UK)

    Drug to prevent early labor raises risk  Jan 14, 2006
    An estimated one in 200 pregnant women in Britain are given the drug to treat an infection called bacterial vaginosis that can cause early labor and pre-term delivery. Women are screened for the infection in the later stages of pregnancy. (MSNBC -- Health)

    Premature birth drug fears  Jan 14, 2006
    The drug is generally prescribed for the condition bacterial vaginosis (BV), which is an infection linked with premature deliveries. Risk. (BBC News -- Health)

    Drug meant to stop early birth 'brings it on instead'  Jan 13, 2006
    The antibiotic metronidazole is given to about one in every 200 women to treat a condition called bacterial vaginosis ... In Britain about one in 20 pregnant women is screened for bacterial vaginosis, and one in 10 of the tests records a positive result ... There is no doubt that bacterial vaginosis is associated with pre-term birth, Professor Sherman said. (Times Online)



    Back to FindHealthNews Home

[ Terms Of Use | Privacy | About ]
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2006